Preliminary scientific tests reveal conolidine could inhibit certain ion channels, reducing neuronal excitability and restricting soreness signals. This system is especially relevant in neuropathic ache, where abnormal signaling results in persistent pain. In addition, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral t